Adipose derived mesenchymal stem cell therapy (Liaocheng People's Hospital)

N/A

Report date: 2023/01/12 15:47:51

Base Information

Drug NameAdipose derived mesenchymal stem cell therapy (Liaocheng People's Hospital)
Drug Alias Name脂肪来源的间充质干细胞疗法-聊城市人民医院Adipose derived mesenchymal stem cells
ClassificationCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsWounds and InjuriesPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLiaocheng People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesLiaocheng People'S Hospital
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesPulmonary Arterial Hypertension
Inactive IndicationsHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A